Related Experiment Video

Updated: Dec 28, 2025

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

42.5K

SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness

Nathaniel J Robinson1, Chevaun D Morrison-Smith2, Alex J Gooding1

  • 1Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Life Science Alliance
|February 20, 2020
PubMed

Insights

Researchers identified SLX4-interacting protein (SLX4IP) as key to breast cancer metastasis recurrence. Targeting telomere maintenance mechanisms (TMMs) involving SLX4IP offers new therapeutic strategies against metastatic breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Metastasis is the primary cause of breast cancer mortality, with limited targeted therapies.
  • Disseminated tumor cells evade detection and therapy, leading to late-stage recurrence.
  • Understanding the mechanisms of recurrence is crucial for improving patient outcomes.

Purpose of the Study:

  • To identify novel regulators of metastatic recurrence in breast cancer.
  • To elucidate the role of SLX4-interacting protein (SLX4IP) in telomere maintenance mechanisms (TMMs).
  • To explore TMMs as therapeutic targets for preventing breast cancer metastasis.

Main Methods:

  • Conducted an unbiased genetic screen to identify regulators of metastatic recurrence.
  • Investigated the function of SLX4IP in governing telomere maintenance mechanisms (TMMs).
  • Assessed the impact of TMM modulation on metastatic progression and patient survival.

Main Results:

  • SLX4IP was identified as a regulator of metastatic recurrence.
  • SLX4IP inactivation suppressed alternative lengthening of telomeres (ALT) and activated telomerase.
  • TMM selection significantly influenced metastatic progression and patient survival across breast cancer subtypes.
  • Pharmacologic and genetic targeting of TMMs induced telomere-dependent cell death and prevented recurrence.

Conclusions:

  • SLX4IP is a potential predictive biomarker for breast cancer progression and metastatic relapse.
  • SLX4IP expression correlates with TMM identity, which has prognostic value.
  • Modulating TMMs presents a novel therapeutic strategy against metastatic breast cancer.

More Related Videos

Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence06:52

Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence

Published on: November 5, 2021

3.5K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.8K

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K